Suppr超能文献

肝脂肪变性对肝切除术后围手术期结局的影响。

Impact of steatosis on perioperative outcome following hepatic resection.

作者信息

Kooby David A, Fong Yuman, Suriawinata Arief, Gonen Mithat, Allen Peter J, Klimstra David S, DeMatteo Ronald P, D'Angelica Michael, Blumgart Leslie H, Jarnagin William R

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Gastrointest Surg. 2003 Dec;7(8):1034-44. doi: 10.1016/j.gassur.2003.09.012.

Abstract

Fatty liver disease may interfere with liver regeneration and is postulated to result in an adverse outcome for patients subjected to partial hepatectomy. This study examines the impact of steatosis on outcome following hepatic resection for neoplasms. All patients with fatty livers (n=325) who underwent hepatectomy between December 1991 and September 2001 were identified from a prospective database. Slides were reviewed and steatosis was quantified as follows: <30% (mild) and > or =30% (marked). Patient data were gathered and compared with results in 160 control patients with normal livers; subjects were matched for age, comorbidity, and extent of liver resection. There were 223 patients with mild and 102 with marked steatosis. Those with steatosis were more likely to be men (59% marked vs. 55% mild vs. 43% control; P=0.01) with a higher body mass index (29.7+/-5.5 marked vs. 28.2+/-5.5 mild vs. 26.0+/-5.4 control; P<0.01), and treated preoperatively with chemotherapy (66% marked vs. 55% mild vs. 38% control; P<0.01). Total (62%, 48%, and 35%; P<0.01) and infective (43%, 24%, and 14%; P<0.01) complications correlated with the degree of steatosis. No difference was observed in complications requiring major medical intervention, hospitalization, or admission to the intensive care unit between groups. On multivariate analysis, steatosis was an independent predictor of complications (P<0.01, risk ratio=3.04, 95% confidence interval=1.7 to 5.54). There was a nonsignificant trend toward higher 60-day mortality in patients with marked steatosis who had lobe or more resections (9.4% marked vs. 5.0% mild vs. 5.0% control; P=0.30). Marked steatosis is an independent predictor of complications following hepatic resection but does not have a significant impact on 60-day mortality. Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution.

摘要

脂肪肝疾病可能会干扰肝脏再生,并据推测会给接受部分肝切除术的患者带来不良后果。本研究探讨了脂肪变性对肝肿瘤切除术后预后的影响。从一个前瞻性数据库中识别出1991年12月至2001年9月期间接受肝切除术的所有脂肪肝患者(n = 325)。对切片进行复查,并将脂肪变性量化如下:<30%(轻度)和≥30%(重度)。收集患者数据,并与160例肝脏正常的对照患者的结果进行比较;根据年龄、合并症和肝切除范围对受试者进行匹配。有223例轻度脂肪变性患者和102例重度脂肪变性患者。脂肪变性患者更可能为男性(重度59% vs. 轻度55% vs. 对照43%;P = 0.01),体重指数更高(重度29.7±5.5 vs. 轻度28.2±5.5 vs. 对照26.0±5.4;P < 0.01),且术前接受化疗(重度66% vs. 轻度55% vs. 对照38%;P < 0.01)。总体并发症(62%、48%和35%;P < 0.01)和感染性并发症(43%、24%和14%;P < 0.01)与脂肪变性程度相关。各组之间在需要重大医疗干预、住院或入住重症监护病房的并发症方面未观察到差异。多因素分析显示,脂肪变性是并发症的独立预测因素(P < 0.01,风险比 = 3.04,95%置信区间 = 1.7至5.54)。在接受叶或更大范围切除的重度脂肪变性患者中,60天死亡率有升高趋势但无统计学意义(重度9.4% vs. 轻度5.0% vs. 对照5.0%;P = 0.30)。重度脂肪变性是肝切除术后并发症的独立预测因素,但对60天死亡率无显著影响。当有指征时,仅脂肪变性本身不应排除对肿瘤进行积极的肝切除;然而,对于接受大范围切除的重度脂肪变性患者,仍应谨慎对待。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验